Literature DB >> 12970120

Thrombin and platelet activation.

Lawrence F Brass1.   

Abstract

The accumulation of thrombin at sites of vascular injury provides one of the chief means for recruiting platelets into a growing hemostatic plug. Studies completed over the past 10 years show that platelet responses to thrombin are mediated by a subset of G protein-coupled receptors known as protease-activated receptors. These receptors are activated on cleavage by thrombin, initiating the intracellular signaling events needed to transform mobile, nonadhesive platelets into cells that can participate in the growth of an immobile hemostatic plug. How this is accomplished is the subject of this review.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970120     DOI: 10.1378/chest.124.3_suppl.18s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  86 in total

1.  Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1.

Authors:  Prafull S Gandhi; Zhiwei Chen; Enrico Di Cera
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

2.  Effects of AZD0837, a novel direct thrombin inhibitor, on the electrophysiological properties of the human heart: a randomized, double-blind, parallel-group, placebo-controlled study.

Authors:  Håkan Walfridsson; Birgitta Johansson; Anders Englund; Göran Kennebäck; Jonas Schwieler; Ole Kongstad; Karin Wåhlander; Anders R Malm; Nils Edvardsson
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Arf6 plays an early role in platelet activation by collagen and convulxin.

Authors:  Wangsun Choi; Zubair A Karim; Sidney W Whiteheart
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

4.  Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates.

Authors:  Michael Holinstat; Anita M Preininger; Stephen B Milne; W James Hudson; H Alex Brown; Heidi E Hamm
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

5.  Platelet retraction force measurements using flexible post force sensors.

Authors:  Xin M Liang; Sangyoon J Han; Jo-Anna Reems; Dayong Gao; Nathan J Sniadecki
Journal:  Lab Chip       Date:  2010-01-20       Impact factor: 6.799

6.  Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.

Authors:  B Steppich; F Dobler; L C Brendel; G Hessling; S L Braun; A L Steinsiek; I Deisenhofer; A Hyseni; M Roest; I Ott
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

7.  A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting.

Authors:  Adriana M G Ibelli; Tae K Kim; Creston C Hill; Lauren A Lewis; Mariam Bakshi; Stephanie Miller; Lindsay Porter; Albert Mulenga
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

8.  Murine platelets are not regulated by O-linked beta-N-acetylglucosamine.

Authors:  Garland L Crawford; Gerald W Hart; Sidney W Whiteheart
Journal:  Arch Biochem Biophys       Date:  2008-03-21       Impact factor: 4.013

9.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

10.  Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.

Authors:  Wei-Fan Chen; Jie-Jen Lee; Chao-Chien Chang; Kuan-Hong Lin; Shwu-Huey Wang; Joen-Rong Sheu
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.